查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1663306

介入性神經放射學 - 市場洞察、競爭格局、2032年市場預測

Interventional Neuroradiology - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2024年全球介入神經放射學市場規模價值 311.9887億美元，預計到2032年將達到 520.8152億美元，預測期內（2025-2032年）的年複合成長率為 6.66%。介入性神經放射學的需求主要由神經系統疾病發生率的上升所驅動，尤其是腦動脈瘤、缺血性中風和動靜脈畸形（AVM）。這些疾病的日益普及推動了對微創診斷和治療程序的需求，以改善患者的治療效果並縮短恢復時間。

此外，技術進步將在預測期內（2025-2032年）推動市場成長發揮關鍵作用。下一代流量分流器、柔性微導管、增強成像技術和機器人輔助干預等發展顯著提高了介入性神經放射學手術的準確性、安全性和有效性。這些進步使得以前被認為無法手術或手術有風險的複雜神經系統疾病能夠得到治療。

此外，人工智慧和機器學習演算法在診斷成像中的整合增強早期檢測和治療計劃，加速介入神經放射學解決方案的採用。人們對微創手術的偏好日益增加，加上病患意識的提高和醫療保健基礎設施的改善，進一步推動了各個地區的市場擴張。

介入性神經放射學的市場動態

由於神經系統疾病盛行率上升、中風發生率增加以及治療設備技術的持續進步，介入性神經放射學市場預計在預測期內將大幅成長。

根據腦動脈瘤基金會（2023）的資料，美國約有 670萬人患有未破裂的腦動脈瘤，每年報告的動脈瘤破裂病例約為 30,000 例。腦動脈瘤破裂可導致蛛網膜下腔出血等危及生命的病症，需要緊急介入治療，例如血管內線圈栓塞或使用血流分流器。腦動脈瘤發生率的不斷上升導致了人們認識的提高和診斷能力的提高，這因而又導致了對先進的介入性神經放射學（INR）設備的需求增加。早期發現和治療可顯著降低死亡率並改善長期效果，進一步推動市場成長。

中風疫情也是刺激市場需求的重要因素。根據《全球中風情形說明書（2022）》預測，2022年全球將發生約1,222萬例中風，其中超過760萬例為缺血性中風，佔所有中風的62%。缺血性中風是由於動脈阻塞而發生的，而機械血栓切除術和支架取出術等介入性神經放射學技術對於恢復血流和降低長期殘疾風險非常重要。及時介入可顯著改善患者的復健和生存，推動 INR 技術在急性護理環境中的採用。

介入性神經放射學領域的技術創新進一步推動市場擴張。這些進展包括開發更靈活、更耐用、生物相容性的下一代支架和流量分流器，提高性能並減少支架內血栓形成和裝置移位等併發症。此外，微導管和微導絲的技術創新提高了腦部複雜血管網路導航的精確度和成功率，可以更安全、更有效地治療複雜的動脈瘤和動靜脈畸形（AVM）。機器人輔助干預和即時成像等尖端技術也使微創手術成為可能，可縮短恢復時間並降低風險，越來越受到患者和醫療保健提供者的歡迎。

儘管存在這些積極因素，但市場仍面臨著與介入設備相關的併發症（如血管穿孔、設備移位和血栓栓塞）以及設備審批的監管環境挑戰等挑戰。監管機構需要大量臨床資料來確保安全性和有效性，這可能會延遲產品發布並增加開發成本。

然而，全球神經和腦血管疾病負擔不斷加重、人們對早期干預益處的認識不斷提高以及技術的持續進步預計將克服挑戰並推動2025-2032年預測期內介入神經放射學市場的成長。

本報告對全球介入神經放射學市場進行調查分析，包括市場規模和預測、過去三年的產品/技術發展、市場的主要參與者以及可用的機會。

目錄

第1章 介入性神經放射學市場報告簡介

第2章 介入性神經放射學市場執行摘要

  • 市場概況

第3章 競爭格局

第4章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 介入性神經放射學市場關鍵因素分析

  • 介入性神經放射學市場驅動因素
  • 介入性神經放射學市場的限制與挑戰
  • 介入性神經放射學市場機會

第6章 介入性神經放射學市場的波特五力分析

第7章 介入性神經放射學市場評估

  • 依設備
    • 微導絲
    • 微導管
    • 導流支架
    • 栓塞線圈
    • 神經血管栓塞裝置
    • 其他
  • 疾病
    • 腦動脈瘤
    • 顱內腫瘤
    • 急性缺血性中風
    • 其他疾病
  • 依最終用戶
    • 醫院
    • 門診手術中心
  • 區域
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 介入性神經放射學市場中的公司與產品概況

  • Stryker
  • Boston Scientific Corporation
  • MicroVention Inc.
  • Cook
  • Mediterra
  • Johnson & Johnson, Inc.
  • Merit Medical Systems, Inc.
  • Terumo Corporation
  • Penumbra, Inc.
  • MicroPort Scientific Corporation
  • Balt Group
  • AngioDynamics
  • Acandis GmBH
  • Phenox GmbH
  • InspireMD Inc.

第9章 KOL 視角

第10章 專案方法

第11章 關於 DelveInsight

第12章 免責聲明、聯絡我們

Product Code: DIMDCL0065

Interventional Neuroradiology Market by Device (Micro guidewires, Microcatheters, Flow Diversion Stents, Embolization Coils, Neurovascular Embolization Devices, and Others), Disease (Cerebral Aneurysms, Intra-cranial Tumors, Acute Ischemic Strokes, and Other Diseases), End-Users (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising incidence of neurological disorders such as cerebral aneurysms and growing technical advancements in the domain of interventional neuroradiology

The interventional neuroradiology market was valued at USD 31,198.87 million in 2024, growing at a CAGR of 6.66% during the forecast period from 2025 to 2032 to reach USD 52,081.52 million by 2032. The demand for interventional neuroradiology is primarily driven by the rising incidence of neurological disorders, particularly cerebral aneurysms, ischemic strokes, and arteriovenous malformations (AVMs). The growing prevalence of these conditions has heightened the need for minimally invasive diagnostic and therapeutic procedures to improve patient outcomes and reduce recovery times.

Additionally, advancements in technology are playing a pivotal role in propelling market growth during the forecast period (2025 to 2032). Innovations such as the development of next-generation flow diversion devices, highly flexible microcatheters, enhanced imaging technologies, and robot-assisted interventions have significantly improved the precision, safety, and efficacy of interventional neuroradiology procedures. These advancements have enabled the treatment of complex neurological conditions that were previously considered inoperable or carried higher surgical risks.

Furthermore, the integration of artificial intelligence (AI) and machine learning algorithms in diagnostic imaging is enhancing early detection and treatment planning, thereby driving the adoption of interventional neuroradiology solutions. The increasing preference for minimally invasive procedures, combined with rising patient awareness and improved healthcare infrastructure, is further accelerating market expansion across various regions.

Interventional Neuroradiology Market Dynamics:

The interventional neuroradiology market is projected to experience significant growth during the forecast period, driven by the rising prevalence of neurological disorders, increasing incidence of strokes, and ongoing technological advancements in treatment devices.

According to the Brain Aneurysm Foundation (2023), approximately 6.7 million people in the United States have an unruptured brain aneurysm, with around 30,000 cases of aneurysm rupture reported annually. Brain aneurysm ruptures can lead to life-threatening conditions such as subarachnoid hemorrhage and require urgent interventional procedures like endovascular coiling or the use of flow diverters. The increasing prevalence of brain aneurysms has resulted in heightened awareness, improved diagnostic capabilities, and a corresponding rise in demand for advanced interventional neuroradiology (INR) devices. Early detection and treatment significantly reduce mortality and improve long-term outcomes, further propelling market growth.

Stroke prevalence is another critical factor fueling market demand. According to the Global Stroke Fact Sheet (2022), there were approximately 12.22 million incident stroke cases globally in 2022, with over 7.6 million ischemic strokes accounting for 62% of all strokes. Ischemic strokes occur due to blocked arteries, and interventional neuroradiology techniques such as mechanical thrombectomy and stent retrievers are essential in restoring blood flow and reducing the risk of long-term disability. Timely interventions significantly improve patient recovery and survival rates, which has boosted the adoption of INR procedures across emergency care settings.

Technological innovations in the interventional neuroradiology field further support market expansion. Advancements include the development of next-generation stents and flow diverters with improved flexibility, durability, and biocompatibility, which enhance performance and reduce complications such as in-stent thrombosis or device migration. Moreover, innovations in microcatheter and microguidewire technologies have improved precision and navigability through the brain's complex vascular network, allowing for safer and more effective treatment of complex aneurysms and arteriovenous malformations (AVMs). Cutting-edge technologies like robot-assisted interventions and real-time imaging advancements are also enabling minimally invasive procedures with shorter recovery times and reduced risks, which are becoming increasingly preferred by both patients and healthcare providers.

Despite these positive drivers, the market faces challenges such as complications associated with interventional devices (e.g., vessel perforation, device migration, or thromboembolic events) and the stringent regulatory landscape for device approval. Regulatory authorities require extensive clinical data to ensure safety and efficacy, which can delay product launches and increase development costs.

Nevertheless, the rising global burden of neurological and cerebrovascular diseases, increasing awareness of early intervention benefits, and continuous technological progress are expected to outweigh the challenges, thereby propelling the growth of the interventional neuroradiology market during the forecast period from 2025 to 2032.

Interventional Neuroradiology Market Segment Analysis:

Interventional Neuroradiology Market by Device (Micro guidewires, Microcatheters, Flow Diversion Stents, Embolization Coils, Neurovascular Embolization Devices, and Others), Disease (Cerebral Aneurysms, Intra-cranial Tumors, Acute Ischemic Strokes, and Other Diseases), End-Users (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device segment of the interventional neuroradiology market, the flow diversion stents category is projected to amass a significant revenue share in 2024, driven by their versatile applications, clinical advantages, and increasing product approvals that are collectively fueling market demand during the forecast period.

Flow diversion stents have emerged as a preferred treatment option for managing complex intracranial aneurysms, particularly those that are large, wide-necked, or fusiform cases that are challenging to treat with traditional methods such as endovascular coiling. These stents work by redirecting blood flow away from the aneurysm sac, promoting endothelial growth along the stent, and ultimately sealing off the aneurysm over time. Flow diversion therapy is especially beneficial for aneurysms that have recurred after previous treatments, offering a reliable alternative with long-term durability and lower recurrence rates.

One of the key benefits of flow diversion stents is their minimally invasive nature. The procedure is typically performed using a catheter-based delivery system through the femoral or radial artery, reducing the risks associated with open craniotomy and shortening recovery times. Unlike traditional coiling, direct manipulation of the aneurysm sac is avoided, significantly reducing the risk of rupture during the procedure. Moreover, many flow diversion techniques do not require adjunctive devices like coils or balloons, simplifying the intervention process and minimizing device-related complications.

The market growth for flow diversion stents is further fueled by a surge in product approvals and technological advancements. For instance, in December 2023, MicroPort(R) NeuroTech(TM) received approval from the Brazilian National Health Surveillance Agency (ANVISA) for its Tubridge(R) Vascular Reconstruction Device. The Tubridge(R) is a dense-mesh stent applying flow diversion therapy principles, designed specifically to treat large or giant wide-necked intracranial aneurysms. Such innovations offer improved device flexibility, better wall apposition, and enhanced navigability through tortuous cerebral vessels, making them suitable for treating complex cases with greater precision and safety.

Additionally, the rising prevalence of intracranial aneurysms, increased awareness of early diagnosis, and growing demand for minimally invasive interventions are key contributors to the expanding market share of flow diversion stents. As more healthcare facilities adopt these advanced devices and as clinical guidelines increasingly support their use for various aneurysm types, the adoption rate is expected to rise globally.

Therefore, owing to the aforementioned factors including their clinical efficacy, safety profile, technological advancements, and regulatory approvals the flow diversion stents category is poised to register significant growth, thereby driving the overall expansion of the interventional neuroradiology market during the forecast period (2025 to 2032).

North America is expected to dominate the overall interventional neuroradiology market:

North America is anticipated to account for the largest share of the interventional neuroradiology market in 2024, driven by a large patient pool affected by ischemic strokes, transient ischemic attacks (TIA), and a growing geriatric population. Additional factors such as advanced healthcare infrastructure, technological innovations, and robust product development pipelines are further propelling market growth in the region.

According to the Centers for Disease Control and Prevention (CDC) 2023, approximately 795,000 people in the United States experience a stroke each year, with 87% being ischemic strokes caused by a blockage of blood flow to the brain. The high prevalence of ischemic strokes, coupled with the need for rapid intervention to improve patient outcomes, has increased the demand for interventional neuroradiology devices, including mechanical thrombectomy devices, stent retrievers, and aspiration catheters.

The aging population in North America further contributes to the rising incidence of strokes and TIAs. According to the US Census Bureau 2021 report, over 54 million adults aged 65 and older were living in the United States in 2021. This demographic is expected to rise to approximately 85.7 million by 2050, representing nearly 20% of the overall US population. The elderly population, particularly those above 50 years, are at a higher risk of ischemic strokes and TIA due to age-related vascular changes such as arterial narrowing, arteriosclerosis, and atherosclerosis. This underscores the growing need for minimally invasive treatments to manage these conditions effectively.

Additionally, the high adoption rate of innovative technologies and the presence of major market players in the region foster continuous product launches and regulatory approvals. For example, the United States Food and Drug Administration (FDA) has expedited the approval of various neurovascular devices to enhance stroke care. The region's robust research and development activities, favorable reimbursement policies, and widespread use of advanced imaging technologies further support early diagnosis and prompt intervention, contributing to market expansion.

The strategic collaborations between healthcare providers, academic institutions, and medical device manufacturers in North America also play a crucial role in accelerating product innovations and expanding treatment accessibility. Moreover, the increasing awareness of stroke symptoms and improved emergency medical services are enabling faster treatment initiation, which is critical in ischemic stroke management.

Therefore, the combination of a growing stroke patient population, an aging demographic, technological advancements, and a supportive regulatory environment positions North America as the leading region in the interventional neuroradiology market during the forecast period (2025 to 2032).

Interventional Neuroradiology Market Key Players:

Some of the key market players operating in the interventional neuroradiology market include Stryker, Boston Scientific Corporation, MicroVention Inc., Cook, Mediterra, Johnson & Johnson, Inc., Merit Medical Systems, Inc., Terumo Corporation, Penumbra, Inc., MicroPort Scientific Corporation, Balt Group, AngioDynamics, Acandis GmBH, Phenox, and InspireMD Inc.

Recent Developmental Activities in the Interventional Neuroradiology Market:

  • In October 2023, the Royal Australian and New Zealand College of Radiologists (RANZCR) launched the Standards of Practice for Interventional Radiology and Interventional Neuroradiology during its 72nd Annual Scientific Meeting (ASM) held in Adelaide. These standards aim to enhance patient safety, optimize clinical outcomes, and ensure consistent quality of care in interventional radiology and neuroradiology procedures across the region.
  • In June 2022, Stryker announced a partnership with Carmeda to develop an advanced flow diverter featuring active drug coating technology. This collaboration aims to enhance aneurysm treatment by improving device biocompatibility and reducing the risk of thrombosis, ultimately offering better long-term patient outcomes in the management of complex cerebral aneurysms.

Key Takeaways from the Interventional Neuroradiology Market Report Study

  • Market size analysis for current interventional neuroradiology market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the interventional neuroradiology market.
  • Various opportunities available for the other competitors in the interventional neuroradiology market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current interventional neuroradiology market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for interventional neuroradiology market growth in the coming future?

Target Audience Who Can be Benefited from this Interventional Neuroradiology Market Report Study

  • Interventional neuroradiology product providers
  • Research organizations and consulting companies
  • Interventional Neuroradiology - related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in the interventional neuroradiology market
  • Various end-users who want to know more about the interventional neuroradiology market and the latest technological developments in the interventional neuroradiology market.

Frequently Asked Questions for the Interventional Neuroradiology Market:

1. What is meant by interventional neuroradiology?

  • Interventional Neuroradiology is a subspecialty of radiology that focuses on diagnosing and treating disorders of the central nervous system (CNS), including the brain, spine, head, and neck. It combines expertise in neuroanatomy, imaging techniques, and endovascular (within the blood vessels) methods.

2. What is the market for interventional neuroradiology?

  • The interventional neuroradiology market was valued at USD 31,198.87 million in 2024, growing at a CAGR of 6.66% during the forecast period from 2025 to 2032 to reach USD 52,081.52 million by 2032.

3. What are the drivers for the global interventional neuroradiology market?

  • The interventional neuroradiology market is primarily being boosted by the rising incidence of neurological disorders such as cerebral aneurysms. Additionally, increasing technological advancements in the domain of interventional neuroradiology is another key factor, which is responsible for contributing to the growth of the interventional neuroradiology market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global interventional neuroradiology market?

  • Some of the key market players operating in the interventional neuroradiology market include Stryker, Boston Scientific Corporation, MicroVention Inc., Cook, Mediterra, Johnson & Johnson, Inc., Merit Medical Systems, Inc., Terumo Corporation, Penumbra, Inc., MicroPort Scientific Corporation, Balt Group, AngioDynamics, Acandis GmBH, Phenox, and InspireMD Inc.

5. Which region has the highest share in the global interventional neuroradiology market?

  • North America is expected to dominate the overall interventional neuroradiology market during the forecast period, 2025 to 2032. This is due to the presence of a large patient pool suffering from ischemic stroke, and transient ischemic attack (TIA). Additionally, the rising geriatric population, the presence of developed and sophisticated healthcare infrastructure, and a highly viable market in terms of product development, and launches are some of the factors driving the growth of the interventional neuroradiology market in North America.

Table of Contents

1. Interventional Neuroradiology Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Interventional Neuroradiology Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Interventional Neuroradiology Market Key Factors Analysis

  • 5.1. Interventional Neuroradiology Market Drivers
    • 5.1.1. Rising prevalence of neurological disorders
    • 5.1.2. Growing technical advancements and Innovation
    • 5.1.3. Growing Government Initiatives and favorable Reimbursement policies
  • 5.2. Interventional Neuroradiology Market Restraints and Challenges
    • 5.2.1. Complications associated with the use of interventional neuroradiology devices
    • 5.2.2. Stringent regulatory approval of the devices
  • 5.3. Interventional Neuroradiology Market Opportunities
    • 5.3.1. Integration of artificial intelligence (AI) and machine learning algorithms in diagnostic imaging for enhancing early detection and treatment planning

6. Interventional Neuroradiology Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Interventional Neuroradiology Market Assessment

  • 7.1. By Device
    • 7.1.1. Micro guidewires
    • 7.1.2. Microcatheters
    • 7.1.3. Flow Diversion Stents
    • 7.1.4. Embolization Coils
    • 7.1.5. Neurovascular Embolization Devices
    • 7.1.6. Others
  • 7.2. By Disease
    • 7.2.1. Cerebral Aneurysms
    • 7.2.2. Intracranial Tumors
    • 7.2.3. Acute Ischemic Strokes
    • 7.2.4. Other Diseases
  • 7.3. By End-Users
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.1.2. Canada Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.1.3. Mexico Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.2. Europe
      • 7.4.2.1. France Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.2.2. Germany Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.2.3. United Kingdom Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.2.4. Italy Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.2.5. Spain Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.2.6. Rest of Europe Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.3.2. Japan Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.3.3. India Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.3.4. Australia Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.3.5. South Korea Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.3.6. Rest of Asia-Pacific Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.4.2. Africa Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.4.3. South America Interventional Neuroradiology Market Size in USD million (2022-2032)

8. Interventional Neuroradiology Market Company and Product Profiles

  • 8.1. Stryker
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Boston Scientific Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. MicroVention Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Cook
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Mediterra
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Johnson & Johnson, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Merit Medical Systems, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Terumo Corporation
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Penumbra, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. MicroPort Scientific Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Balt Group
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. AngioDynamics
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Acandis GmBH
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Phenox GmbH
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. InspireMD Inc.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Interventional Neuroradiology Market in Global (2022-2032)
  • Table 3: Interventional Neuroradiology Market in Global by Device (2022-2032)
  • Table 4: Interventional Neuroradiology Market in Global by Disease (2022-2032)
  • Table 5: Interventional Neuroradiology Market in Global by End-User (2022-2032)
  • Table 6: Interventional Neuroradiology Market in Global by Geography (2022-2032)
  • Table 7: Interventional Neuroradiology Market in North America (2022-2032)
  • Table 8: Interventional Neuroradiology Market in the United States (2022-2032)
  • Table 9: Interventional Neuroradiology Market in Canada (2022-2032)
  • Table 10: Interventional Neuroradiology Market in Mexico (2022-2032)
  • Table 11: Interventional Neuroradiology Market in Europe (2022-2032)
  • Table 12: Interventional Neuroradiology Market in France (2022-2032)
  • Table 13: Interventional Neuroradiology Market in Germany (2022-2032)
  • Table 14: Interventional Neuroradiology Market in United Kingdom (2022-2032)
  • Table 15: Interventional Neuroradiology Market in Italy (2022-2032)
  • Table 16: Interventional Neuroradiology Market in Spain (2022-2032)
  • Table 17: Interventional Neuroradiology Market in the Rest of Europe (2022-2032)
  • Table 18: Interventional Neuroradiology Market in Asia-Pacific (2022-2032)
  • Table 19: Interventional Neuroradiology Market in China (2022-2032)
  • Table 20: Interventional Neuroradiology Market in Japan (2022-2032)
  • Table 21: Interventional Neuroradiology Market in India (2022-2032)
  • Table 22: Interventional Neuroradiology Market in Australia (2022-2032)
  • Table 23: Interventional Neuroradiology Market in South Korea (2022-2032)
  • Table 24: Interventional Neuroradiology Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Interventional Neuroradiology Market in the Rest of the World (2022-2032)
  • Table 26: Interventional Neuroradiology Market in the Middle East (2022-2032)
  • Table 27: Interventional Neuroradiology Market in Africa (2022-2032)
  • Table 28: Interventional Neuroradiology Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Interventional Neuroradiology Market in Global (2022-2032)
  • Figure 3: Interventional Neuroradiology Market in Global by Device (2022-2032)
  • Figure 4: Interventional Neuroradiology Market in Global by Disease (2022-2032)
  • Figure 5: Interventional Neuroradiology Market in Global by End-User (2022-2032)
  • Figure 6: Interventional Neuroradiology Market in Global by Geography (2022-2032)
  • Figure 7: Interventional Neuroradiology Market in North America (2022-2032)
  • Figure 8: Interventional Neuroradiology Market in the United States (2022-2032)
  • Figure 9: Interventional Neuroradiology Market in Canada (2022-2032)
  • Figure 10: Interventional Neuroradiology Market in Mexico (2022-2032)
  • Figure 11: Interventional Neuroradiology Market in Europe (2022-2032)
  • Figure 12: Interventional Neuroradiology Market in France (2022-2032)
  • Figure 13: Interventional Neuroradiology Market in Germany (2022-2032)
  • Figure 14: Interventional Neuroradiology Market in United Kingdom (2022-2032)
  • Figure 15: Interventional Neuroradiology Market in Italy (2022-2032)
  • Figure 16: Interventional Neuroradiology Market in Spain (2022-2032)
  • Figure 17: Interventional Neuroradiology Market in the Rest of Europe (2022-2032)
  • Figure 18: Interventional Neuroradiology Market in Asia-Pacific (2022-2032)
  • Figure 19: Interventional Neuroradiology Market in China (2022-2032)
  • Figure 20: Interventional Neuroradiology Market in Japan (2022-2032)
  • Figure 21: Interventional Neuroradiology Market in India (2022-2032)
  • Figure 22: Interventional Neuroradiology Market in Australia (2022-2032)
  • Figure 23: Interventional Neuroradiology Market in South Korea (2022-2032)
  • Figure 24: Interventional Neuroradiology Market in Rest of Asia-Pacific (2022-2032)
  • Figure 25: Interventional Neuroradiology Market in the Rest of the World (2022-2032)
  • Figure 26: Interventional Neuroradiology Market in the Middle East (2022-2032)
  • Figure 27: Interventional Neuroradiology Market in Africa (2022-2032)
  • Figure 28: Interventional Neuroradiology Market in South America (2022-2032)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis